Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021

Autor: Bajema, Kristina L., Dahl, Rebecca M., Evener, Steve L., Prill, Mila M., Rodriguez-Barradas, Maria C., Marconi, Vincent C., Beenhouwer, David O., Holodniy, Mark, Lucero-Obusan, Cynthia, Brown, Sheldon T., Tremarelli, Maraia, Epperson, Monica, Mills, Lisa, Park, So Hee, Rivera-Dominguez, Gilberto, Morones, Rosalba Gomez, Ahmadi-Izadi, Ghazal, Deovic, Rijalda, Mendoza, Chad, Jeong, Chan, Schrag, Stephanie J., Meites, Elissa, Hall, Aron J., Kobayashi, Miwako, McMorrow, Meredith, Verani, Jennifer R., Thornburg, Natalie J., Surie, Diya, Burnette, Joy, Capo, Gustavo, Epstein, Lauren, Gallini, Julia, Harrison, Telisha, Hartley, Amy, Hernandez, Liliana, Morales, Elena, Patel, Nina, Rooney, Kim, Tanner, Tehquin, Tate, Ernest, Tunson, Ashley, Whitmire, Alexis, Winston, Juton, Elliot, Katherine, Graham, Ilda, Lama, Diki, Pena, Ismael, Perea, Adrienne, Perez, Guerry Anabelle, Simelane, Johane, Smith, Sarah, Tallin, Gabriela, Tisi, Amelia, Lopez, Alonso Arellano, Gonzalez, Miguel Covarrubias, Lengi, Bashir, Tamez, Mariana Vanoye, Aryanfar, Babak, Lee-Chang, Ian, Matolek, Anthony, Poteshkina, Aleksandra, Naeem, Saadia, Goldin, Evan, Agrawal, Madhuri, Lopez, Jessica, Peters, Theresa, Kudryavtseva, Geliya, Cates, Jordan, Kambhampati, Anita

Publikováno v: Morbidity and Mortality Weekly Report

The mRNA COVID-19 vaccines (Moderna and Pfizer-BioNTech) provide strong protection against severe COVID-19, including hospitalization, for at least several months after receipt of the second dose (1,2). However, studies examining immune responses and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a3e0c3116549b72eba0d41245a9a0c
https://doi.org/10.15585/mmwr.mm7049a2